Company intelligence / Profile preview
VISUfarma
Amsterdam, Netherlandsvisufarma.com ↗
- Ownership
- Private
- Employees
- ~175
- Development stage
- Other
01
Overview
VISUfarma has a broad commercial portfolio of ophthalmic products and devices for conditions such as dry eye, glaucoma, eyelid hygiene disorders, and more. The company operates across Europe with a direct sales force in major markets and distributes to over twenty countries through exclusive partners. No specific clinical trial results are highlighted; the focus is on commercialization of approved products.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculesMedical devicesFood supplements
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Partners with US licensing companies for European distribution; specifics not named.
Beyond the preview
Go deeper on VISUfarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VISUfarma.